Declared Dividend • Apr 26
Final dividend increased to €0.24 Dividend of €0.24 is 42% higher than last year. Ex-date: 15th June 2026 Payment date: 19th June 2026 Dividend yield will be 7.7%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is covered by earnings (85% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 22% per year over the past 8 years. However, payments have been volatile during that time. EPS is expected to decline by 16% over the next 2 years. Since a fall of 5.8% would increase the payout ratio to a potentially unsustainable range, the dividend may be at risk. Reported Earnings • Apr 22
Full year 2025 earnings: EPS exceeds analyst expectations while revenues lag behind Full year 2025 results: EPS: €0.44 (up from €0.24 in FY 2024). Revenue: €389.6m (up 5.2% from FY 2024). Net income: €18.8m (up 81% from FY 2024). Profit margin: 4.8% (up from 2.8% in FY 2024). The increase in margin was driven by higher revenue. Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) exceeded analyst estimates by 54%. Revenue is forecast to grow 3.1% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Tillkännagivande • Apr 21
Thrace Plastics Holding Company S.A., Annual General Meeting, May 19, 2026 Thrace Plastics Holding Company S.A., Annual General Meeting, May 19, 2026. Upcoming Dividend • Jan 12
Upcoming dividend of €0.069 per share Eligible shareholders must have bought the stock before 19 January 2026. Payment date: 23 January 2026. Payout ratio is on the higher end at 83% but the company is not cash flow positive. Trailing yield: 5.3%. Within top quartile of Greek dividend payers (4.8%). Higher than average of industry peers (2.9%). Reported Earnings • Nov 26
Third quarter 2025 earnings released: EPS: €0.12 (vs €0.097 in 3Q 2024) Third quarter 2025 results: EPS: €0.12 (up from €0.097 in 3Q 2024). Revenue: €100.1m (up 4.6% from 3Q 2024). Net income: €5.30m (up 28% from 3Q 2024). Profit margin: 5.3% (up from 4.3% in 3Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 2.8% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 32% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Declared Dividend • Nov 19
First half dividend of €0.069 announced Shareholders will receive a dividend of €0.069. Ex-date: 19th January 2026 Payment date: 23rd January 2026 Dividend yield will be 5.9%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is covered by earnings (65% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 25% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 63% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Tillkännagivande • Nov 19
Thrace Plastics Holding Company S.A. to Report Nine Months, 2025 Results on Nov 20, 2025 Thrace Plastics Holding Company S.A. announced that they will report nine months, 2025 results on Nov 20, 2025 Reported Earnings • Sep 22
Second quarter 2025 earnings released: EPS: €0.17 (vs €0.095 in 2Q 2024) Second quarter 2025 results: EPS: €0.17 (up from €0.095 in 2Q 2024). Revenue: €103.7m (up 5.7% from 2Q 2024). Net income: €7.41m (up 81% from 2Q 2024). Profit margin: 7.1% (up from 4.2% in 2Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.8% p.a. on average during the next 3 years, compared to a 3.0% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. Tillkännagivande • Sep 17
Thrace Plastics Holding Company S.A. to Report First Half, 2025 Results on Sep 19, 2025 Thrace Plastics Holding Company S.A. announced that they will report first half, 2025 results on Sep 19, 2025 Reported Earnings • Jun 20
First quarter 2025 earnings released: EPS: €0.011 (vs €0.074 in 1Q 2024) First quarter 2025 results: EPS: €0.011 (down from €0.074 in 1Q 2024). Revenue: €96.4m (up 9.2% from 1Q 2024). Net income: €450.0k (down 86% from 1Q 2024). Profit margin: 0.5% (down from 3.6% in 1Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.1% p.a. on average during the next 2 years, compared to a 3.3% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Tillkännagivande • Jun 17
Thrace Plastics Holding Company S.A. to Report Q1, 2025 Results on Jun 18, 2025 Thrace Plastics Holding Company S.A. announced that they will report Q1, 2025 results Pre-Market on Jun 18, 2025 Upcoming Dividend • Jun 03
Upcoming dividend of €0.17 per share Eligible shareholders must have bought the stock before 10 June 2025. Payment date: 16 June 2025. Payout ratio is on the higher end at 98%, and the cash payout ratio is above 100%. Trailing yield: 6.0%. Lower than top quartile of Greek dividend payers (6.1%). Higher than average of industry peers (2.6%). Tillkännagivande • May 08
Thrace Plastics Holding Company S.A., Annual General Meeting, May 28, 2025 Thrace Plastics Holding Company S.A., Annual General Meeting, May 28, 2025, at 14:00 GTB Standard Time. Location: without the physical presence, of shareholders at the venue., Greece Declared Dividend • Apr 30
Final dividend increased to €0.17 Dividend of €0.17 is 0.7% higher than last year. Ex-date: 10th June 2025 Payment date: 16th June 2025 Dividend yield will be 6.3%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is not adequately covered by earnings (98% earnings payout ratio) nor is it covered by cash flows (dividend approximately 13x free cash flows). The dividend has increased by an average of 25% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 8.5% to bring the payout ratio under control. EPS is expected to grow by 63% over the next 3 years, which is sufficient to bring the dividend into a sustainable range. Reported Earnings • Apr 28
Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Full year 2024 results: EPS: €0.24 (down from €0.41 in FY 2023). Revenue: €370.4m (up 7.2% from FY 2023). Net income: €10.4m (down 42% from FY 2023). Profit margin: 2.8% (down from 5.1% in FY 2023). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 3.8%. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is forecast to grow 2.7% p.a. on average during the next 3 years, compared to a 4.0% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Upcoming Dividend • Jan 16
Upcoming dividend of €0.069 per share Eligible shareholders must have bought the stock before 23 January 2025. Payment date: 29 January 2025. Payout ratio is a comfortable 71% and the cash payout ratio is 84%. Trailing yield: 5.8%. Within top quartile of Greek dividend payers (5.1%). Higher than average of industry peers (2.9%). Reported Earnings • Nov 26
Third quarter 2024 earnings released: EPS: €0.097 (vs €0.14 in 3Q 2023) Third quarter 2024 results: EPS: €0.097 (down from €0.14 in 3Q 2023). Revenue: €95.7m (up 6.7% from 3Q 2023). Net income: €4.15m (down 32% from 3Q 2023). Profit margin: 4.3% (down from 6.8% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 3.5% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 59% per year but the company’s share price has only fallen by 17% per year, which means it has not declined as severely as earnings. Tillkännagivande • Nov 22
Thrace Plastics Holding Company S.A. to Report Nine Months, 2024 Results on Nov 25, 2024 Thrace Plastics Holding Company S.A. announced that they will report nine months, 2024 results on Nov 25, 2024 Reported Earnings • Sep 19
Second quarter 2024 earnings released: EPS: €0.094 (vs €0.12 in 2Q 2023) Second quarter 2024 results: EPS: €0.094 (down from €0.12 in 2Q 2023). Revenue: €98.1m (up 13% from 2Q 2023). Net income: €4.47m (down 11% from 2Q 2023). Profit margin: 4.6% (down from 5.7% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 6.4% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 61% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings. Tillkännagivande • Sep 17
Thrace Plastics Holding Company S.A. to Report First Half, 2024 Results on Sep 18, 2024 Thrace Plastics Holding Company S.A. announced that they will report first half, 2024 results on Sep 18, 2024 Reported Earnings • Jun 04
First quarter 2024 earnings released: EPS: €0.074 (vs €0.088 in 1Q 2023) First quarter 2024 results: EPS: €0.074 (down from €0.088 in 1Q 2023). Revenue: €88.3m (down 5.0% from 1Q 2023). Net income: €3.18m (down 16% from 1Q 2023). Profit margin: 3.6% (down from 4.1% in 1Q 2023). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 6.9% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 57% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Tillkännagivande • Jun 02
Thrace Plastics Holding Company S.A. to Report Q1, 2024 Results on Jun 03, 2024 Thrace Plastics Holding Company S.A. announced that they will report Q1, 2024 results at 1:00 PM, GTB Standard Time on Jun 03, 2024 Upcoming Dividend • May 27
Upcoming dividend of €0.17 per share Eligible shareholders must have bought the stock before 03 June 2024. Payment date: 07 June 2024. Payout ratio is a comfortable 57% and the cash payout ratio is 87%. Trailing yield: 5.7%. Within top quartile of Greek dividend payers (5.7%). Higher than average of industry peers (2.7%). Declared Dividend • Apr 25
Final dividend of €0.17 announced Shareholders will receive a dividend of €0.17. Ex-date: 3rd June 2024 Payment date: 7th June 2024 Dividend yield will be 5.9%, which is higher than the industry average of 2.8%. Sustainability & Growth Dividend is covered by both earnings (58% earnings payout ratio) and cash flows (62% cash payout ratio). The dividend has increased by an average of 18% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 41% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Reported Earnings • Apr 24
Full year 2023 earnings released: EPS: €0.41 (vs €0.60 in FY 2022) Full year 2023 results: EPS: €0.41 (down from €0.60 in FY 2022). Revenue: €345.4m (down 12% from FY 2022). Net income: €17.8m (down 31% from FY 2022). Profit margin: 5.1% (down from 6.5% in FY 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.9% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 47% per year but the company’s share price has only fallen by 7% per year, which means it has not declined as severely as earnings. Tillkännagivande • Apr 20
Thrace Plastics Holding Company S.A. to Report Fiscal Year 2023 Results on Apr 23, 2024 Thrace Plastics Holding Company S.A. announced that they will report fiscal year 2023 results on Apr 23, 2024 Buy Or Sell Opportunity • Feb 13
Now 22% undervalued The stock has been flat over the last 90 days, currently trading at €4.25. The fair value is estimated to be €5.44, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Earnings per share has declined by 33%. For the next 3 years, revenue is forecast to grow by 4.8% per annum. Earnings are also forecast to grow by 19% per annum over the same time period. Upcoming Dividend • Nov 23
Upcoming dividend of €0.069 per share at 5.9% yield Eligible shareholders must have bought the stock before 30 November 2023. Payment date: 06 December 2023. Payout ratio is on the higher end at 79%, however this is supported by cash flows. Trailing yield: 5.9%. Within top quartile of Greek dividend payers (5.2%). Higher than average of industry peers (3.8%). Reported Earnings • Nov 21
Third quarter 2023 earnings released: EPS: €0.14 (vs €0.24 in 3Q 2022) Third quarter 2023 results: EPS: €0.14 (down from €0.24 in 3Q 2022). Revenue: €89.7m (down 13% from 3Q 2022). Net income: €6.14m (down 42% from 3Q 2022). Profit margin: 6.8% (down from 10% in 3Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 3.6% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 33% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Tillkännagivande • Nov 18
Thrace Plastics Holding Company S.A. to Report Nine Months, 2023 Results on Nov 20, 2023 Thrace Plastics Holding Company S.A. announced that they will report nine months, 2023 results on Nov 20, 2023 Buying Opportunity • Nov 13
Now 20% undervalued after recent price drop Over the last 90 days, the stock is down 18%. The fair value is estimated to be €5.14, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.4% over the last 3 years. Earnings per share has declined by 15%. For the next 3 years, revenue is forecast to grow by 3.8% per annum. Earnings is also forecast to grow by 13% per annum over the same time period. Reported Earnings • Sep 24
Second quarter 2023 earnings released: EPS: €0.12 (vs €0.17 in 2Q 2022) Second quarter 2023 results: EPS: €0.12 (down from €0.17 in 2Q 2022). Revenue: €87.1m (down 18% from 2Q 2022). Net income: €5.00m (down 31% from 2Q 2022). Profit margin: 5.7% (down from 6.8% in 2Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 3.1% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 20% per year, which means it is well ahead of earnings. Tillkännagivande • Sep 16
Thrace Plastics Holding Company S.A. to Report First Half, 2023 Results on Sep 19, 2023 Thrace Plastics Holding Company S.A. announced that they will report first half, 2023 results on Sep 19, 2023 Tillkännagivande • Jun 27
Thrace Plastics Holding Company S.A. (ATSE:PLAT) commences an Equity Buyback for 4,341,876 shares, under the authorization approved on May 24, 2023. Thrace Plastics Holding and Commercial S.A. (ATSE:PLAT) commences share repurchases on June 26, 2023, under the program mandated by the shareholders in the Annual General Meeting held on May 24, 2023. As per the mandate, the company is authorized to repurchase up to 4,341,876 shares (with the total treasury shares already owned by the company, from a previous share buyback program, included and aggregated in relation to the above limit). The shares will be repurchased within a price range of €0.5 per share and €10 per share. The authority will expire after 24 months from the date of this decision until May 24, 2025. As of May 24, 2023, the company had 751,396 shares in treasury. New Risk • Jun 10
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Greek stocks, typically moving 5.9% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Minor Risks Dividend is not well covered by cash flows (162% cash payout ratio). Share price has been volatile over the past 3 months (5.9% average weekly change). Profit margins are more than 30% lower than last year (5.5% net profit margin). Valuation Update With 7 Day Price Move • Jun 09
Investor sentiment improves as stock rises 20% After last week's 20% share price gain to €5.15, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 15x in the Chemicals industry in Europe. Total returns to shareholders of 270% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at €5.46 per share. Reported Earnings • May 31
First quarter 2023 earnings released: EPS: €0.088 (vs €0.20 in 1Q 2022) First quarter 2023 results: EPS: €0.088 (down from €0.20 in 1Q 2022). Revenue: €93.0m (down 13% from 1Q 2022). Net income: €3.79m (down 56% from 1Q 2022). Profit margin: 4.1% (down from 8.2% in 1Q 2022). The decrease in margin was driven by lower revenue. Revenue is forecast to grow 5.0% p.a. on average during the next 2 years, compared to a 3.0% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 5% per year but the company’s share price has increased by 38% per year, which means it is tracking significantly ahead of earnings growth. Tillkännagivande • May 25
Thrace Plastics Holding Company S.A. to Report Q1, 2023 Results on May 30, 2023 Thrace Plastics Holding Company S.A. announced that they will report Q1, 2023 results at 1:00 PM, GTB Standard Time on May 30, 2023 Upcoming Dividend • May 24
Upcoming dividend of €0.19 per share at 6.2% yield Eligible shareholders must have bought the stock before 31 May 2023. Payment date: 07 June 2023. Payout ratio is a comfortable 43% but the company is not cash flow positive. Trailing yield: 6.2%. Within top quartile of Greek dividend payers (5.5%). Higher than average of industry peers (3.9%). Reported Earnings • Apr 26
Full year 2022 earnings released: EPS: €0.60 (vs €1.51 in FY 2021) Full year 2022 results: EPS: €0.60 (down from €1.51 in FY 2021). Revenue: €394.4m (down 7.9% from FY 2021). Net income: €25.8m (down 61% from FY 2021). Profit margin: 6.5% (down from 15% in FY 2021). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 2.6% p.a. on average during the next 2 years, compared to a 2.6% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Upcoming Dividend • Jan 23
Upcoming dividend of €0.069 per share Eligible shareholders must have bought the stock before 30 January 2023. Payment date: 03 February 2023. Payout ratio is a comfortable 37% but the company is not cash flow positive. Trailing yield: 5.5%. Within top quartile of Greek dividend payers (4.7%). Higher than average of industry peers (3.7%). Reported Earnings • Dec 02
Third quarter 2022 earnings released: EPS: €0.24 (vs €0.38 in 3Q 2021) Third quarter 2022 results: EPS: €0.24 (down from €0.38 in 3Q 2021). Revenue: €103.4m (down 3.7% from 3Q 2021). Net income: €10.5m (down 36% from 3Q 2021). Profit margin: 10% (down from 15% in 3Q 2021). The decrease in margin was primarily driven by lower revenue. Revenue is forecast to grow 9.0% p.a. on average during the next 3 years, compared to a 3.2% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 41% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 4 were independent directors. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Non Executive Member George Samothrakis was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Sep 17
Second quarter 2022 earnings released: EPS: €0.17 (vs €0.55 in 2Q 2021) Second quarter 2022 results: EPS: €0.17 (down from €0.55 in 2Q 2021). Revenue: €106.5m (down 13% from 2Q 2021). Net income: €7.22m (down 70% from 2Q 2021). Profit margin: 6.8% (down from 19% in 2Q 2021). Revenue is forecast to grow 6.7% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Chemicals industry in Europe. Over the last 3 years on average, earnings per share has increased by 58% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • May 23
Upcoming dividend of €0.16 per share Eligible shareholders must have bought the stock before 30 May 2022. Payment date: 03 June 2022. Payout ratio is a comfortable 23% but the company is paying out more than the cash it is generating. Trailing yield: 7.7%. Within top quartile of Greek dividend payers (4.7%). Higher than average of industry peers (3.4%). Reported Earnings • May 17
First quarter 2022 earnings: EPS and revenues exceed analyst expectations First quarter 2022 results: EPS: €0.20 (down from €0.56 in 1Q 2021). Revenue: €106.3m (down 4.6% from 1Q 2021). Net income: €8.67m (down 65% from 1Q 2021). Profit margin: 8.2% (down from 22% in 1Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue exceeded analyst estimates by 5.9%. Earnings per share (EPS) also surpassed analyst estimates by 5.4%. Over the next year, revenue is expected to shrink by 18% compared to a 16% growth forecast for the industry in Greece. Over the last 3 years on average, earnings per share has increased by 73% per year but the company’s share price has only increased by 27% per year, which means it is significantly lagging earnings growth. Tillkännagivande • May 10
Thrace Plastics Holding and Commercial S.A. to Report Q1, 2022 Results on May 16, 2022 Thrace Plastics Holding and Commercial S.A. announced that they will report Q1, 2022 results on May 16, 2022 Board Change • Apr 27
Less than half of directors are independent There are 5 new directors who have joined the board in the last 3 years. Of these new board members, 4 were independent directors. The company's board is composed of: 5 independent directors. 6 non-independent directors. Independent Non-Executive Vice Chairman Theodoros Kitsos was the last independent director to join the board, commencing their role in 2021. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Lack of board continuity. Reported Earnings • Apr 17
Full year 2021 earnings: EPS and revenues exceed analyst expectations Full year 2021 results: EPS: €1.51 (up from €0.93 in FY 2020). Revenue: €428.4m (up 26% from FY 2020). Net income: €65.4m (up 61% from FY 2020). Profit margin: 15% (up from 12% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 5.9%. Earnings per share (EPS) also surpassed analyst estimates by 5.4%. Over the next year, revenue is expected to shrink by 20% compared to a 17% growth forecast for the industry in Greece. Over the last 3 years on average, earnings per share has increased by 85% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Apr 14
Thrace Plastics Holding and Commercial S.A., Annual General Meeting, May 25, 2022 Thrace Plastics Holding and Commercial S.A., Annual General Meeting, May 25, 2022. Tillkännagivande • Apr 01
Thrace Plastics Holding and Commercial S.A. to Report Fiscal Year 2021 Results on Apr 14, 2022 Thrace Plastics Holding and Commercial S.A. announced that they will report fiscal year 2021 results on Apr 14, 2022 Upcoming Dividend • Nov 24
Upcoming dividend of €0.11 per share Eligible shareholders must have bought the stock before 01 December 2021. Payment date: 08 December 2021. Trailing yield: 3.2%. Lower than top quartile of Greek dividend payers (3.8%). Higher than average of industry peers (2.4%). Reported Earnings • Sep 12
Second quarter 2021 earnings released: EPS €0.55 (vs €0.21 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: €122.9m (up 51% from 2Q 2020). Net income: €23.8m (up 160% from 2Q 2020). Profit margin: 19% (up from 11% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 84% per year but the company’s share price has only increased by 54% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Jun 08
Thrace Plastics Holding and Commercial S.A. (ATSE:PLAT) commences an Equity Buyback Plan for 4,341,876 shares, representing 13.46% of its issued share capital under the authorization approved on May 21, 2021. Thrace Plastics Holding and Commercial S.A. (ATSE:PLAT) commences share repurchases on June 7, 2021, under the program mandated by the shareholders in the Annual General Meeting held on May 21, 2021. As per the mandate, the company is authorized to repurchase up to 4,341,876 shares, representing 13.46% of its issued share capital. The shares will be repurchased within a price range of €0.5 per share and €10 per share. The program will expire after 24 months or until May 21, 2023. As of May 21, 2021, the company had 32,263,573 shares outstanding. Reported Earnings • May 16
First quarter 2021 earnings released: EPS €0.56 (vs €0.078 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: €111.4m (up 51% from 1Q 2020). Net income: €24.4m (up €21.0m from 1Q 2020). Profit margin: 22% (up from 4.6% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 69% per year but the company’s share price has only increased by 34% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • May 12
Investor sentiment improved over the past week After last week's 18% share price gain to €5.78, the stock trades at a forward P/E ratio of 6x. Average forward P/E is 21x in the Chemicals industry in Europe. Total returns to shareholders of 159% over the past three years. Reported Earnings • Apr 14
Full year 2020 earnings released: EPS €0.93 (vs €0.085 in FY 2019) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2020 results: Revenue: €339.7m (up 3.6% from FY 2019). Net income: €40.7m (up €36.9m from FY 2019). Profit margin: 12% (up from 1.1% in FY 2019). The increase in margin was primarily driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 39% per year but the company’s share price has only increased by 23% per year, which means it is significantly lagging earnings growth. Tillkännagivande • Mar 19
Thrace Plastics Holding and Commercial S.A., Annual General Meeting, May 21, 2021 Thrace Plastics Holding and Commercial S.A., Annual General Meeting, May 21, 2021. Is New 90 Day High Low • Mar 08
New 90-day high: €4.23 The company is up 20% from its price of €3.54 on 08 December 2020. The Greek market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €43.74 per share. Valuation Update With 7 Day Price Move • Feb 11
Investor sentiment improved over the past week After last week's 16% share price gain to €4.20, the stock is trading at a trailing P/E ratio of 8x, up from the previous P/E ratio of 6.9x. This compares to an average P/E of 26x in the Chemicals industry in Europe. Total returns to shareholders over the past three years are 86%. Is New 90 Day High Low • Feb 08
New 90-day high: €4.00 The company is up 51% from its price of €2.65 on 10 November 2020. The Greek market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 9.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €42.96 per share. Tillkännagivande • Jan 22
Thrace Plastics Holding and Commercial S.A., Annual General Meeting, Feb 11, 2021 Thrace Plastics Holding and Commercial S.A., Annual General Meeting, Feb 11, 2021, at 16:00 E. Europe Standard Time. Is New 90 Day High Low • Dec 28
New 90-day high: €3.79 The company is up 62% from its price of €2.34 on 29 September 2020. The Greek market is up 19% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 6.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €43.15 per share. Is New 90 Day High Low • Dec 07
New 90-day high: €3.51 The company is up 78% from its price of €1.97 on 08 September 2020. The Greek market is up 17% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 3.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €32.42 per share. Reported Earnings • Nov 19
Third quarter 2020 earnings released: EPS €0.36 The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2020 results: Revenue: €98.4m (up 31% from 3Q 2019). Net income: €15.5m (up 299% from 3Q 2019). Profit margin: 16% (up from 5.2% in 3Q 2019). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 9% per year whereas the company’s share price has increased by 10% per year. Valuation Update With 7 Day Price Move • Nov 19
Market bids up stock over the past week After last week's 17% share price gain to €3.10, the stock is trading at a trailing P/E ratio of 12.1x, up from the previous P/E ratio of 10.4x. This compares to an average P/E of 22x in the Chemicals industry in Europe. Total returns to shareholders over the past three years are 36%. Is New 90 Day High Low • Nov 19
New 90-day high: €3.10 The company is up 61% from its price of €1.92 on 20 August 2020. The Greek market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 4.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is €31.98 per share. Is New 90 Day High Low • Oct 07
New 90-day high: €2.60 The company is up 37% from its price of €1.90 on 09 July 2020. The Greek market is flat over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 8.0% over the same period. Reported Earnings • Sep 23
First half earnings released Over the last 12 months the company has reported total profits of €11.2m, up 49% from the prior year. Total revenue was €328.0m over the last 12 months, up 4.9% from the prior year. Is New 90 Day High Low • Sep 22
New 90-day high: €2.26 The company is up 24% from its price of €1.82 on 24 June 2020. The Greek market is down 1.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 10.0% over the same period.